Oncogenic BRAF, through decreased MITF expression and enhanced IL-1α and IL-1β secretion, triggers PD-L1 and PD-L2 expression in tumor-associated fibroblasts which also contributes to suppression of tumor-infiltrating T cell function [116]. The gene discussed is BRAF; the disease is neoplasm.